Related Experiment Video
Updated: Apr 23, 2026

06:02
Multi-timescale Microscopy Methods for the Characterization of Fluorescently-labeled Microbubbles for Ultrasound-Triggered Drug Release
Published on: June 12, 2021
4.8K
The influence of blood on targeted microbubbles
Joshua Owen1, Philip Grove1, Paul Rademeyer1
1Institute of Biomedical Engineering, University of Oxford, Old Road Campus Research Building, Oxford OX3 7DQ, UK.
Journal of the Royal Society, Interface
|September 26, 2014
Summary
Targeted drug delivery faces challenges due to whole blood effects. This study reveals blood significantly reduces targeting efficiency, impacting clinical translation and assay design for therapeutic molecules.
Area of Science:
- Biomedical Engineering
- Drug Delivery Systems
- Nanotechnology
Background:
- Targeted drug delivery aims to improve therapeutic efficacy and reduce side effects.
- Clinical translation of targeted delivery systems is hindered by a poor correlation between in vitro and in vivo results.
- In vitro assays often fail to replicate the complex environment of the human body, particularly blood.
Purpose of the Study:
- To investigate the impact of whole blood characteristics on the efficiency of targeted drug delivery.
- To identify a potential reason for the discrepancy between in vitro and in vivo outcomes in targeted delivery research.
- To provide insights for improving the design of targeted drug delivery systems and their evaluation methods.
Main Methods:
- Two distinct model systems were utilized for evaluating targeted delivery.
- Biochemical and magnetic targeting strategies were employed in the model systems.
- Targeting efficiency was compared under conditions using whole blood versus saline under identical flow parameters.
Main Results:
- Whole blood significantly reduces the targeting efficiency of therapeutic molecules compared to saline.
- This reduction in efficiency was observed across both biochemical and magnetic targeting model systems.
- The presence of blood components demonstrably impacts the performance of targeted delivery strategies.
Conclusions:
- The characteristics of whole blood are a critical factor influencing targeted drug delivery efficiency.
- Current in vitro assays may not adequately predict in vivo performance due to the exclusion of blood's effects.
- Future development of targeted delivery systems and associated assays must account for blood's impact for successful clinical translation.

